MAIA Biotechnology MAIA
NYSE MAIA
$1.13 0.00 (-0.39%)
As of: Oct 22, 2026 · 9:49 AM EDT

MAIA Biotechnology (MAIA) Interest Expenses (2021 - 2024)

Updated

MAIA Biotechnology (MAIA) recorded Interest Expenses of -$28.00 in Q4 2024.

Analysis

MAIA Biotechnology (MAIA) Interest Expenses (2021 - 2024) Analysis & Trends

For FY2024, MAIA Biotechnology reported Interest Expenses of $57.00, down 99.2% from FY2023.

  • Annual Interest Expenses has declined for three straight years, with a three-year compound annual growth rate of -95.9% (FY2021 to FY2024).
  • Across earlier years, Interest Expenses came in at $6,863 in FY2023 (-1.5%), $6,967 in FY2022 (-99.2%) and $827,539 in FY2021.
  • The Q4 2024 figure is the lowest quarterly Interest Expenses in data going back to Q2 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Eli Lilly 1,148.13 Bn 1,116.72 Bn 19.71 Bn -
2 Johnson & Johnson 630.09 Bn 548.62 Bn 17.26 Bn 281.00 Mn
3 AbbVie 498.99 Bn 472.10 Bn 12.70 Bn -
4 Merck 374.92 Bn 329.30 Bn 12.21 Bn -
5 Novartis Ag 300.99 Bn 264.98 Bn 11.24 Bn 462.00 Mn
6 Astrazeneca 264.63 Bn 238.32 Bn 12.86 Bn 435.00 Mn
7 Amgen 239.15 Bn 194.55 Bn 7.24 Bn 673.00 Mn
8 Gilead Sciences 192.23 Bn 166.43 Bn 6.22 Bn 247.00 Mn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn -
10 MAIA Biotechnology 69.31 Mn -12.25 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -28.00
Sep 30, 2024 85.00
Sep 30, 2023 1.00
Jun 30, 2023 1,715.00
Mar 31, 2023 5,147.00
Dec 31, 2022 5,147.00
Sep 30, 2022 1,716.00
Jun 30, 2022 104.00
Sep 30, 2021 451,306.00
Jun 30, 2021 313,466.00
API Access

MAIA Biotechnology Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=MAIA&period=max&api_key=YOUR_API_KEY